A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer

Abstract Background Long non-coding RNAs (lncRNAs) play crucial roles in cancer pathogenesis, including colorectal cancer (CRC). Distinct lncRNA transcripts from the same gene show diverse regulatory roles in cancer. The MIR100HG, a lncRNA gene characterized by multiple transcript variants, has been...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingrui Dai, Yuhua Shi, Hailin Zhao, Yue Hu, Xianling Cong, Bin Yu, Haihong Zhang, Xianghui Yu, Hui Wu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-025-02280-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234456535105536
author Mingrui Dai
Yuhua Shi
Hailin Zhao
Yue Hu
Xianling Cong
Bin Yu
Haihong Zhang
Xianghui Yu
Hui Wu
author_facet Mingrui Dai
Yuhua Shi
Hailin Zhao
Yue Hu
Xianling Cong
Bin Yu
Haihong Zhang
Xianghui Yu
Hui Wu
author_sort Mingrui Dai
collection DOAJ
description Abstract Background Long non-coding RNAs (lncRNAs) play crucial roles in cancer pathogenesis, including colorectal cancer (CRC). Distinct lncRNA transcripts from the same gene show diverse regulatory roles in cancer. The MIR100HG, a lncRNA gene characterized by multiple transcript variants, has been implicated in promoting CRC oncogenesis. However, the specific functions of individual MIR100HG transcripts in tumorigenesis remain unclear. Methods We explored the MIR100HG transcripts upregulated by TGFβ1 treated in CRC cells using RNA-Seq and characterized a novel transcript in CRC cells and tumor tissues via qRT-PCR. Chromatin immunoprecipitation and luciferase assays revealed this transcript’s upstream regulation. Functional experiments were performed in vitro and in mouse models. The molecular mechanism was elucidated through RNA-seq, RNA pull-down, mass spectrometry, RNA immunoprecipitation and co-immunoprecipitation. Finally, we evaluated the transcript’s therapeutic potential by treating mouse model tumors with antisense oligonucleotide. Results We identified a novel transcript, MIR100HG-L, which retains more portion of exon 1 compared to the previously reported shorter transcript. MIR100HG-L was transcriptionally upregulated by TGFβ/SMAD signaling and exhibited elevated expression in CRC tissues. Functionally, this transcript was demonstrated to promote CRC cell proliferation, suppress apoptosis and enhance drug resistance. Mechanistically, MIR100HG-L specifically interacted with BCLAF1, serving as a protein scaffold to connect BCLAF1 with splicing factors. This interaction significantly induced BCLAF1-mediated splicing events of oncogenes related to apoptosis and DNA damage response, enhancing their expression and contributing to CRC development. MIR100HG-L-targeted antisense therapy reduced tumor growth and increased cetuximab sensitivity. Conclusions Our study reveals a novel MIR100HG transcript induced by TGFβ/SMAD signaling and explores its distinct oncogenic mechanism through a structure-specific interaction with the BCLAF1. These findings suggest distinct MIR100HG transcripts may exert diverse functions and lead to the identification of novel molecular markers and therapeutic targets for CRC.
format Article
id doaj-art-87a6e91024ce4ef4a9d3ad246bd13fbd
institution Kabale University
issn 1478-811X
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Cell Communication and Signaling
spelling doaj-art-87a6e91024ce4ef4a9d3ad246bd13fbd2025-08-20T04:03:07ZengBMCCell Communication and Signaling1478-811X2025-07-0123112010.1186/s12964-025-02280-2A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancerMingrui Dai0Yuhua Shi1Hailin Zhao2Yue Hu3Xianling Cong4Bin Yu5Haihong Zhang6Xianghui Yu7Hui Wu8National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin UniversityNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin UniversityNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin UniversityDepartment of Biobank, The China-Japan Union Hospital of Jilin UniversityDepartment of Biobank, The China-Japan Union Hospital of Jilin UniversityNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin UniversityNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin UniversityNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin UniversityNational Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin UniversityAbstract Background Long non-coding RNAs (lncRNAs) play crucial roles in cancer pathogenesis, including colorectal cancer (CRC). Distinct lncRNA transcripts from the same gene show diverse regulatory roles in cancer. The MIR100HG, a lncRNA gene characterized by multiple transcript variants, has been implicated in promoting CRC oncogenesis. However, the specific functions of individual MIR100HG transcripts in tumorigenesis remain unclear. Methods We explored the MIR100HG transcripts upregulated by TGFβ1 treated in CRC cells using RNA-Seq and characterized a novel transcript in CRC cells and tumor tissues via qRT-PCR. Chromatin immunoprecipitation and luciferase assays revealed this transcript’s upstream regulation. Functional experiments were performed in vitro and in mouse models. The molecular mechanism was elucidated through RNA-seq, RNA pull-down, mass spectrometry, RNA immunoprecipitation and co-immunoprecipitation. Finally, we evaluated the transcript’s therapeutic potential by treating mouse model tumors with antisense oligonucleotide. Results We identified a novel transcript, MIR100HG-L, which retains more portion of exon 1 compared to the previously reported shorter transcript. MIR100HG-L was transcriptionally upregulated by TGFβ/SMAD signaling and exhibited elevated expression in CRC tissues. Functionally, this transcript was demonstrated to promote CRC cell proliferation, suppress apoptosis and enhance drug resistance. Mechanistically, MIR100HG-L specifically interacted with BCLAF1, serving as a protein scaffold to connect BCLAF1 with splicing factors. This interaction significantly induced BCLAF1-mediated splicing events of oncogenes related to apoptosis and DNA damage response, enhancing their expression and contributing to CRC development. MIR100HG-L-targeted antisense therapy reduced tumor growth and increased cetuximab sensitivity. Conclusions Our study reveals a novel MIR100HG transcript induced by TGFβ/SMAD signaling and explores its distinct oncogenic mechanism through a structure-specific interaction with the BCLAF1. These findings suggest distinct MIR100HG transcripts may exert diverse functions and lead to the identification of novel molecular markers and therapeutic targets for CRC.https://doi.org/10.1186/s12964-025-02280-2Colorectal cancerLncRNAMIR100HGTranscriptTumorigenesisBCLAF1
spellingShingle Mingrui Dai
Yuhua Shi
Hailin Zhao
Yue Hu
Xianling Cong
Bin Yu
Haihong Zhang
Xianghui Yu
Hui Wu
A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer
Cell Communication and Signaling
Colorectal cancer
LncRNA
MIR100HG
Transcript
Tumorigenesis
BCLAF1
title A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer
title_full A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer
title_fullStr A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer
title_full_unstemmed A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer
title_short A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer
title_sort novel mir100hg transcript enhances tumorigenesis by inducing bclaf1 mediated alternative splicing in colorectal cancer
topic Colorectal cancer
LncRNA
MIR100HG
Transcript
Tumorigenesis
BCLAF1
url https://doi.org/10.1186/s12964-025-02280-2
work_keys_str_mv AT mingruidai anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT yuhuashi anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT hailinzhao anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT yuehu anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT xianlingcong anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT binyu anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT haihongzhang anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT xianghuiyu anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT huiwu anovelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT mingruidai novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT yuhuashi novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT hailinzhao novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT yuehu novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT xianlingcong novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT binyu novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT haihongzhang novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT xianghuiyu novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer
AT huiwu novelmir100hgtranscriptenhancestumorigenesisbyinducingbclaf1mediatedalternativesplicingincolorectalcancer